Clinical trials
Parkinsonism clinical trials
Below are recruiting parkinsonism clinical trials, each written for real people, not researchers. We’re tracking 735 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06456684Recruiting
AV133 PET scan study in early Parkinson's disease
This study uses a special PET scan to look at a protein (VMAT2) in the brain that is linked to Parkinson's disease. It helps researchers understand early changes in people with newly diagnosed Parkinson's or those at high risk of developing it.
Beijing, Beijing MunicipalityAges 30 years+ - NCT07839793RecruitingPhase 4
Using a device and app for Parkinson's medication
This study tests a new way to take your Parkinson's medication using a special device and an app, with the goal of making it easier to manage your symptoms. You'll use the device for 12 weeks and share your experiences through questionnaires.
Stockholm, Stockholm CountyAges 30 years+ - NCT07833748Recruiting
Combined thinking and movement training for Parkinson's disease
This study tests a program that combines cognitive (thinking) exercises with physical (movement) training for people with Parkinson's disease. The goal is to see if this combined approach is feasible and beneficial for improving both mental and motor symptoms.
Ferrara, FEAges 18 years+ - NCT07832695Recruiting
Brain stimulation plus practice for Parkinson's disease
This study tests whether a type of brain stimulation, called repetitive transcranial magnetic stimulation (rTMS), combined with guided practice can improve movement and daily function in people with Parkinson's disease. It may help you move better and do everyday tasks more easily.
Taipei, Zhongzheng Dist.Ages 18 years+ - NCT07810296Recruiting
Comparing two tremor medications for Parkinson's disease
This trial compares two commonly used medications, benzhexol and procyclidine, to see which works better for controlling tremor in people with Parkinson's disease. If you have bothersome tremors despite your current levodopa/carbidopa treatment, this study could help find a more effective option.
Lahore, Punjab ProvinceAges 40–70 - NCT07804615RecruitingPhase 2
Investigational drug for tremor from Parkinson's disease
This study is testing an investigational drug for Parkinson's-related tremor (shaking). It aims to see if the drug can help reduce tremor in people whose symptoms are not fully controlled by current treatment.
Scottsdale, ArizonaAges 18–65 - NCT07802509Recruiting
summary
safeEffectiveness
Valens, Canton of St. GallenAges 18 years+ - NCT07808606Enrolling by invitation
Hula dancing to improve balance in Parkinson's disease
This trial tests whether taking part in a 24-week hula dancing program can improve balance and movement for people with Parkinson's disease. It may help you stay active and reduce your risk of falling.
Honolulu, HawaiiAges 18 years+ - NCT07798271Recruiting
Optimizing deep brain stimulation for Parkinson's disease
This study is for people with Parkinson's disease who already have a deep brain stimulator (a device that sends electrical pulses to the brain) and still have motor fluctuations (times when symptoms come and go). The researchers want to see if adapting the device's settings can better control symptoms than the current standard settings.
Davis, CaliforniaAges 18 years+ - NCT07798700Recruiting
Biofluid research for brain and movement disorders
This study collects blood, spinal fluid, and other samples from people with brain or movement disorders, their family members, and healthy volunteers. The goal is to find better ways to diagnose and understand these conditions.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07790744Recruiting
Brain imaging study for early Parkinson's signs in people with REM sleep disorder
This study uses MRI scans to look at the brain in people with REM sleep behavior disorder (RBD), a condition that can be an early sign of Parkinson's disease. By comparing them with healthy volunteers, researchers hope to find early markers of Parkinson's that could lead to earlier diagnosis and treatment.
HvidovreAges 18 years+ - NCT07787299Recruiting
Wearable sensors for monitoring tremor in Parkinson's disease
This study tests whether wearable sensors can accurately measure tremor and other movement symptoms in people with Parkinson's disease or essential tremor. Participating may help improve how doctors monitor symptoms at home.
Edinburgh, EdinburghAges 18 years+ - NCT06548256Recruiting
Probiotic for Parkinson's Symptoms
This trial tests whether a probiotic called Clostridium butyricum can help with both movement and non-movement symptoms of Parkinson's disease. It aims to see if improving gut health can ease symptoms.
Kaohsiung CityAges 20–90 - NCT07780461Recruiting
Testing a physical function assessment for Parkinson's disease
This study is testing a set of physical tests (called the Short Physical Performance Battery) to see if they are a good way to measure physical function in people with Parkinson's disease. By participating, you help doctors better understand how to assess mobility and balance in Parkinson's, which could improve future care.
Pontevedra, PontevedraAges 18 years+ - NCT07777419Recruiting
Thinking and mood after brain stimulation for Parkinson's
This study looks at how deep brain stimulation (a treatment that uses mild electrical pulses to help control movement) affects thinking and mood in people with Parkinson's disease. It is a joint study by a Swiss university hospital that uses records from usual care and tests over time.
BernAges 18–75 - NCT06540989RecruitingEarly Phase 1
Speech therapy with computer feedback for Parkinson's
This study tests a new speech therapy approach for people with Parkinson's disease who have mild to moderate speech problems. It uses a computer program that listens to your speech and helps you practice speaking more clearly.
New York, New YorkAges 50–80 - NCT07774312Recruiting
Comparing tTIS treatment intervals to standard care for Parkinson's
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
Shanghai, Shanghai MunicipalityAges 50–85 - NCT06570421Recruiting
Nerve stimulation for Parkinson's and essential tremor
This study tests a non-invasive nerve stimulation device for reducing tremors in people with Parkinson's disease or essential tremor. It follows up participants from a previous trial to see if benefits last up to 24 months.
OstravaAges 18 years+ - NCT06580977Recruiting
Exercise and memory in Parkinson's disease
This study tests whether a supervised exercise program can improve memory and thinking in people with Parkinson's disease. You may be able to join if you are between 50 and 80, have mild to moderate Parkinson's, and can walk independently.
Heidelberg, Baden-WurttembergAges 50–80 - NCT05854524Recruiting
Exercise program to protect the brain in Parkinson’s disease
This trial studies whether doing regular moderate aerobic exercise can help protect the brain in people with Parkinson’s disease. It also includes people without Parkinson’s to compare exercise effects, using fitness and safety screening to keep everyone safe.
Las Vegas, NevadaAges 30–85 - NCT07734181Recruiting
Music Therapy for Parkinson's Disease
This trial tests whether music therapy can help people with Parkinson's disease. It might improve movement, mood, or quality of life.
Arlesheim, Basel-LandschaftAges 50–79 - NCT07725562RecruitingPhase 2/Phase 3
VG081821AC tablets for early to mid-stage Parkinson's disease
This trial tests a new oral medication, VG081821AC, in people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement symptoms and slow the progression of the condition, and it may offer a new treatment option for those not yet on levodopa.
BeijingAges 18–80 - NCT07730073Recruiting
LSVT-LOUD therapy for voice and speech in Parkinson's disease
This study tests whether LSVT-LOUD, a speech therapy program, can improve voice, speech, and quality of life in people with Parkinson's disease who have voice or speech problems. Participants must be native Turkish speakers, aged 40-80, with mild to moderate Parkinson's.
Kâğıthane, IstanbulAges 40–80 - NCT06598878Recruiting
AR-assisted walking training for Parkinson's
This trial tests walking training with augmented reality (AR) goggles to help with movement in Parkinson's disease. It may help improve your gait and balance.
TaoyuanAges 20 years+
Hear when a new Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinsonism?
- Yes. Clin2 currently lists 735 recruiting parkinsonism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinsonism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinsonism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.